#Tandem24 ASTCT great topics will be tweeting some info

#Tandem24 The PTCTC ovarian tissues cryopreservation the controversy

#TANDEM24 The PTCTC role of cytoreduction pre hct some studies from, to do or not to do, only in select patients ##bmtsm

Dr. Rohtesh Mehta Fred Hutch Cancer Center showing how productive using the CIBMTR data sets can be. This is just one year of productivity! Incredible. #Tandem24

Minor HAg load in MHC class I is associated with organ specificity/lung GVHD and may be used as predictor for GVHD development. Targeting mHAg load may be a therapeutic target. Dr. Catherine Wu ASTCT #Tandem24

Congrats Daniel Chandra on his poster presentation today! We are all so proud of you and happy you will be joining us! ASTCT #Tandem24 OHSU Knight Cancer Institute

Ruxolitinib 1.5% cream for cutaneous cGVHD presented by Dr. Alina Markova. ASTCT #Tandem24

#tandem24 #bmtsm Al Malki: relapse risk very low in those achieving full donor chimerism by NGS assay. All TCR-T treated pts achieved MRD negativity, including one who was MRD positive after alloHCT but before the TCR-T infusion.

Capitalizing on graft manipulation! Encouraging results seen with adoptive cell therapy and T cell replete graft with RIC PTCY. Monzr M. AlMalki, MD ASTCT #Tandem24

#tandem24 #bmtsm McCurdy: Ph 1/2 study exploring lower dose PTCy, an important issue for older age allo recipients. Intermediate dose PTCy after MAC haploBMt was shown in a pilot study to be safe and assoc w low aGVHD risk but perhaps more cGVHD than standard PTCy.

Best abstract session-👏Dr. McCurdy. Lower dose PTCY 25mg/kg D+3 and +4/MMF/sirolimus in setting of RIC bone marrow graft MMUD or haplo was safe, protective of GVHD, low relapse, faster engraftment and excellent OS. ASTCT #Tandem24

Great abstract on Post-CAR19 cytopenia associated with clonal hematopoiesis. 👏Dr. Mark Hamilton MD PhD ASTCT #Tandem24

Graft rejection post transplant driven by interferon gamma with biomarkers LAG3 and CXCL11. Can we prevent graft rejection by blocking interferon gamma signaling in high risk patients? Nice work Tony Sabulski, MD ASTCT #Tandem24

NMDP reception! Donor and Recipient meet up! My heart is full - thank you for reminding us of the true meaning of our work! ☺️👏👏❤️

#Tandem24 #phodocs Prakash Satwani is the recipient of the prestigious George Buchanan Lectureship 2024 American Society of Pediatric Hematology/Oncology outstanding mentorship & contributions in peds hemoncbmt a powerhouse+ +he's doing phenomenal work #bmt for the poor in 🇮🇳 #ASPHO2024 #supermentor #visionary

Such a fun night with great company! Thank you CIBMTR team and Dr. Kristin Page! ASTCT #Tandem24

Congrats Dr. Otterson on retirement! OSU Fellowship class 2018!

The Inside Scoop: How To Be Successful Using CIBMTR Data! #Tandem25 CIBMTR

Western Blood Conference 2025!

Work hard play more! WBC2025